ONCOLYTICS BIOTECH INC.
CIK 0001129928 · QID Q13529450
Industry: Pharmaceutical Preparations
| Fact | Value | Period | Source |
|---|---|---|---|
| accounts_payable | {"amount": 3405000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} | 2026-06-30 | sec_edgar |
| accounts_payable | {"amount": 2681000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} | 2026-03-31 | sec_edgar |
| accounts_payable | {"amount": 3504000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} | 2025-12-31 | sec_edgar |
| accounts_payable | {"amount": 756000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} | 2024-12-31 | sec_edgar |
| capex | {"amount": 6000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currenc | 2026-06-30 | sec_edgar |
| capex | {"amount": 6000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currenc | 2026-03-31 | sec_edgar |
| capex | {"amount": 6000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currenc | 2025-12-31 | sec_edgar |
| capex | {"amount": 1000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currenc | 2025-06-30 | sec_edgar |
| capex | {"amount": 1000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currenc | 2025-03-31 | sec_edgar |
| capex | {"amount": 174000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "curre | 2024-12-31 | sec_edgar |
| cash_and_equivalents | {"amount": 4115000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency" | 2026-06-30 | sec_edgar |
| cash_and_equivalents | {"amount": 5493000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency" | 2026-03-31 | sec_edgar |
| cash_and_equivalents | {"amount": 5202000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency" | 2025-12-31 | sec_edgar |
| cash_and_equivalents | {"amount": 11079000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency | 2024-12-31 | sec_edgar |
| cash_and_restricted_cash | {"amount": 4115000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCash | 2026-06-30 | sec_edgar |
| cash_and_restricted_cash | {"amount": 5493000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCash | 2026-03-31 | sec_edgar |
| cash_and_restricted_cash | {"amount": 5202000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCash | 2025-12-31 | sec_edgar |
| cash_and_restricted_cash | {"amount": 10721000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCas | 2025-06-30 | sec_edgar |
| cash_and_restricted_cash | {"amount": 10645000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCas | 2025-03-31 | sec_edgar |
| cash_and_restricted_cash | {"amount": 11079000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCas | 2024-12-31 | sec_edgar |
| cash_and_restricted_cash | {"amount": 26397000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCas | 2023-12-31 | sec_edgar |
| cashflow_financing | {"amount": 14385000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "cur | 2026-06-30 | sec_edgar |
| cashflow_financing | {"amount": 7614000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "curr | 2026-03-31 | sec_edgar |
| cashflow_financing | {"amount": 14120000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "cur | 2025-12-31 | sec_edgar |
| cashflow_financing | {"amount": 8277000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "curr | 2025-06-30 | sec_edgar |
| cashflow_financing | {"amount": 4183000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "curr | 2025-03-31 | sec_edgar |
| cashflow_financing | {"amount": 5028000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "curr | 2024-12-31 | sec_edgar |
| cashflow_investing | {"amount": -6000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "curren | 2026-06-30 | sec_edgar |
| cashflow_investing | {"amount": -6000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "curren | 2026-03-31 | sec_edgar |
| cashflow_investing | {"amount": -6000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "curren | 2025-12-31 | sec_edgar |
| cashflow_investing | {"amount": -1000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "curren | 2025-06-30 | sec_edgar |
| cashflow_investing | {"amount": -1000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "curren | 2025-03-31 | sec_edgar |
| cashflow_investing | {"amount": -174000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "curr | 2024-12-31 | sec_edgar |
| cashflow_operating | {"amount": -15431000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cu | 2026-06-30 | sec_edgar |
| cashflow_operating | {"amount": -7293000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cur | 2026-03-31 | sec_edgar |
| cashflow_operating | {"amount": -20112000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cu | 2025-12-31 | sec_edgar |
| cashflow_operating | {"amount": -8839000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cur | 2025-06-30 | sec_edgar |
| cashflow_operating | {"amount": -4733000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cur | 2025-03-31 | sec_edgar |
| cashflow_operating | {"amount": -19883000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "cu | 2024-12-31 | sec_edgar |
| common_shares_issued | {"unit": "shares", "value": 124637521, "concept": "us-gaap:CommonStockSharesIssued"} | 2026-06-30 | sec_edgar |
| common_shares_issued | {"unit": "shares", "value": 116128162, "concept": "us-gaap:CommonStockSharesIssued"} | 2026-03-31 | sec_edgar |
| common_shares_issued | {"unit": "shares", "value": 108021271, "concept": "us-gaap:CommonStockSharesIssued"} | 2025-12-31 | sec_edgar |
| common_shares_issued | {"unit": "shares", "value": 80020131, "concept": "us-gaap:CommonStockSharesIssued"} | 2024-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 127510505, "concept": "dei:EntityCommonStockSharesOutstanding" | 2026-08-10 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 124637521, "concept": "us-gaap:CommonStockSharesOutstanding"} | 2026-06-30 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 119354067, "concept": "dei:EntityCommonStockSharesOutstanding" | 2026-05-12 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 116128162, "concept": "us-gaap:CommonStockSharesOutstanding"} | 2026-03-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 116128162, "concept": "dei:EntityCommonStockSharesOutstanding" | 2026-03-23 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 108021271, "concept": "us-gaap:CommonStockSharesOutstanding"} | 2025-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 80020131, "concept": "us-gaap:CommonStockSharesOutstanding"} | 2024-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 74423960, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2023-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 61327914, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2022-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 55043789, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2021-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 46166980, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2020-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 32198453, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2019-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 17399749, "concept": "dei:EntityCommonStockSharesOutstanding"} | 2018-12-31 | sec_edgar |
| common_shares_outstanding | {"unit": "shares", "value": 141805722, "concept": "dei:EntityCommonStockSharesOutstanding" | 2017-12-31 | sec_edgar |
| current_assets | {"amount": 7069000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} | 2026-06-30 | sec_edgar |
| current_assets | {"amount": 7487000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} | 2026-03-31 | sec_edgar |
| current_assets | {"amount": 6844000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} | 2025-12-31 | sec_edgar |
| current_assets | {"amount": 12436000, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} | 2024-12-31 | sec_edgar |
| current_liabilities | {"amount": 5225000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} | 2026-06-30 | sec_edgar |
| current_liabilities | {"amount": 5423000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} | 2026-03-31 | sec_edgar |
| current_liabilities | {"amount": 6101000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} | 2025-12-31 | sec_edgar |
| current_liabilities | {"amount": 4885000, "concept": "us-gaap:LiabilitiesCurrent", "currency": "USD"} | 2024-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 127510505} | 2026-08-10 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 119354067} | 2026-05-12 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 116128162} | 2026-03-23 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 80020131} | 2024-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 74423960} | 2023-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 61327914} | 2022-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 55043789} | 2021-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 46166980} | 2020-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 32198453} | 2019-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 17399749} | 2018-12-31 | sec_edgar |
| dei:EntityCommonStockSharesOutstanding | {"unit": "shares", "value": 141805722} | 2017-12-31 | sec_edgar |
| dei:EntityPublicFloat | {"amount": 72100000, "currency": "USD"} | 2025-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.08, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2026-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.16, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2026-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.08, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2026-03-31 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.3, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2025-12-31 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.06, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2025-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.11, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2025-06-30 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.06, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2025-03-31 | sec_edgar |
| eps_basic | {"per": "shares", "amount": -0.3, "concept": "us-gaap:EarningsPerShareBasic", "currency": | 2024-12-31 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.16, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2026-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.08, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2026-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.08, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2026-03-31 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.3, "concept": "us-gaap:EarningsPerShareDiluted", "currency" | 2025-12-31 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.11, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2025-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.06, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2025-06-30 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.06, "concept": "us-gaap:EarningsPerShareDiluted", "currency | 2025-03-31 | sec_edgar |
| eps_diluted | {"per": "shares", "amount": -0.3, "concept": "us-gaap:EarningsPerShareDiluted", "currency" | 2024-12-31 | sec_edgar |
| income_tax_expense | {"amount": 101000, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} | 2026-06-30 | sec_edgar |
| income_tax_expense | {"amount": 101000, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} | 2026-06-30 | sec_edgar |
| income_tax_expense | {"amount": 79000, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} | 2025-12-31 | sec_edgar |
| income_tax_expense | {"amount": 61000, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} | 2025-06-30 | sec_edgar |
| income_tax_expense | {"amount": 61000, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} | 2025-06-30 | sec_edgar |
| income_tax_expense | {"amount": 95000, "concept": "us-gaap:IncomeTaxExpenseBenefit", "currency": "USD"} | 2024-12-31 | sec_edgar |
| industry_sic | {"code": "2834", "scheme": "SIC", "description": "Pharmaceutical Preparations"} | sec_edgar | |
| net_income | {"amount": -9442000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| net_income | {"amount": -18685000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| net_income | {"amount": -9243000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2026-03-31 | sec_edgar |
| net_income | {"amount": -28759000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2025-12-31 | sec_edgar |
| net_income | {"amount": -9988000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| net_income | {"amount": -5277000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| net_income | {"amount": -4711000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2025-03-31 | sec_edgar |
| net_income | {"amount": -22794000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} | 2024-12-31 | sec_edgar |
| observed_web_domain | {"via": "wikidata:P856", "domain": "oncolyticsbiotech.com"} | robots_obs | |
| operating_expenses | {"amount": 18660000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_expenses | {"amount": 9379000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_expenses | {"amount": 9281000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2026-03-31 | sec_edgar |
| operating_expenses | {"amount": 28725000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2025-12-31 | sec_edgar |
| operating_expenses | {"amount": 9672000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_expenses | {"amount": 4651000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_expenses | {"amount": 5021000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2025-03-31 | sec_edgar |
| operating_expenses | {"amount": 25542000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} | 2024-12-31 | sec_edgar |
| operating_income | {"amount": -9379000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_income | {"amount": -18660000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_income | {"amount": -9281000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2026-03-31 | sec_edgar |
| operating_income | {"amount": -28725000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2025-12-31 | sec_edgar |
| operating_income | {"amount": -9672000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_income | {"amount": -4651000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2025-06-30 | sec_edgar |
| operating_income | {"amount": -5021000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2025-03-31 | sec_edgar |
| operating_income | {"amount": -25542000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} | 2024-12-31 | sec_edgar |
| operating_lease_liability | {"amount": 448000, "concept": "us-gaap:OperatingLeaseLiability", "currency": "USD"} | 2026-06-30 | sec_edgar |
| operating_lease_liability | {"amount": 508000, "concept": "us-gaap:OperatingLeaseLiability", "currency": "USD"} | 2026-03-31 | sec_edgar |
| operating_lease_liability | {"amount": 563000, "concept": "us-gaap:OperatingLeaseLiability", "currency": "USD"} | 2025-12-31 | sec_edgar |
| ppe_net | {"amount": 202000, "concept": "us-gaap:PropertyPlantAndEquipmentNet", "currency": "USD"} | 2026-06-30 | sec_edgar |
| ppe_net | {"amount": 218000, "concept": "us-gaap:PropertyPlantAndEquipmentNet", "currency": "USD"} | 2026-03-31 | sec_edgar |
| ppe_net | {"amount": 228000, "concept": "us-gaap:PropertyPlantAndEquipmentNet", "currency": "USD"} | 2025-12-31 | sec_edgar |
| ppe_net | {"amount": 286000, "concept": "us-gaap:PropertyPlantAndEquipmentNet", "currency": "USD"} | 2024-12-31 | sec_edgar |
| pretax_income | {"amount": -9341000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTax | 2026-06-30 | sec_edgar |
| pretax_income | {"amount": -18584000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTa | 2026-06-30 | sec_edgar |
| pretax_income | {"amount": -28680000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTa | 2025-12-31 | sec_edgar |
| pretax_income | {"amount": -9927000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTax | 2025-06-30 | sec_edgar |
| pretax_income | {"amount": -5216000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTax | 2025-06-30 | sec_edgar |
| pretax_income | {"amount": -22699000, "concept": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTa | 2024-12-31 | sec_edgar |
| retained_earnings | {"amount": -448180000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency" | 2026-06-30 | sec_edgar |
| retained_earnings | {"amount": -438738000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency" | 2026-03-31 | sec_edgar |
| retained_earnings | {"amount": -429495000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency" | 2025-12-31 | sec_edgar |
| retained_earnings | {"amount": -400736000, "concept": "us-gaap:RetainedEarningsAccumulatedDeficit", "currency" | 2024-12-31 | sec_edgar |
| rnd_expense | {"amount": 8814000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} | 2026-06-30 | sec_edgar |
| rnd_expense | {"amount": 4262000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} | 2026-06-30 | sec_edgar |
| rnd_expense | {"amount": 4552000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} | 2026-03-31 | sec_edgar |
| rnd_expense | {"amount": 13314000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD" | 2025-12-31 | sec_edgar |
| rnd_expense | {"amount": 4716000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} | 2025-06-30 | sec_edgar |
| rnd_expense | {"amount": 1916000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} | 2025-06-30 | sec_edgar |
| rnd_expense | {"amount": 2800000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD"} | 2025-03-31 | sec_edgar |
| rnd_expense | {"amount": 15443000, "concept": "us-gaap:ResearchAndDevelopmentExpense", "currency": "USD" | 2024-12-31 | sec_edgar |
| sga_expense | {"amount": 9846000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "USD | 2026-06-30 | sec_edgar |
| sga_expense | {"amount": 5117000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "USD | 2026-06-30 | sec_edgar |
| sga_expense | {"amount": 4729000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "USD | 2026-03-31 | sec_edgar |
| sga_expense | {"amount": 15411000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2025-12-31 | sec_edgar |
| sga_expense | {"amount": 4956000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "USD | 2025-06-30 | sec_edgar |
| sga_expense | {"amount": 2735000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "USD | 2025-06-30 | sec_edgar |
| sga_expense | {"amount": 2221000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "USD | 2025-03-31 | sec_edgar |
| sga_expense | {"amount": 10099000, "concept": "us-gaap:GeneralAndAdministrativeExpense", "currency": "US | 2024-12-31 | sec_edgar |
| share_based_compensation | {"amount": 4087000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2026-06-30 | sec_edgar |
| share_based_compensation | {"amount": 2299000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2026-03-31 | sec_edgar |
| share_based_compensation | {"amount": 3104000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2025-12-31 | sec_edgar |
| share_based_compensation | {"amount": 1207000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2025-06-30 | sec_edgar |
| share_based_compensation | {"amount": 845000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2025-03-31 | sec_edgar |
| share_based_compensation | {"amount": 1982000, "concept": "us-gaap:ShareBasedCompensation", "currency": "USD"} | 2024-12-31 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 116036833, "concept": "us-gaap:WeightedAverageNumberOfSharesOu | 2026-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 119739942, "concept": "us-gaap:WeightedAverageNumberOfSharesOu | 2026-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 112292579, "concept": "us-gaap:WeightedAverageNumberOfSharesOu | 2026-03-31 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 95857147, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2025-12-31 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 87833107, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2025-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 90999586, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2025-06-30 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 84631445, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2025-03-31 | sec_edgar |
| shares_wavg_basic | {"unit": "shares", "value": 76482914, "concept": "us-gaap:WeightedAverageNumberOfSharesOut | 2024-12-31 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 116036833, "concept": "us-gaap:WeightedAverageNumberOfDilutedS | 2026-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 119739942, "concept": "us-gaap:WeightedAverageNumberOfDilutedS | 2026-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 112292579, "concept": "us-gaap:WeightedAverageNumberOfDilutedS | 2026-03-31 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 95857147, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2025-12-31 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 87833107, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2025-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 90999586, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2025-06-30 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 84631445, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2025-03-31 | sec_edgar |
| shares_wavg_diluted | {"unit": "shares", "value": 76482914, "concept": "us-gaap:WeightedAverageNumberOfDilutedSh | 2024-12-31 | sec_edgar |
| stockholders_equity | {"amount": -6167000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2026-06-30 | sec_edgar |
| stockholders_equity | {"amount": -5130000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2026-03-31 | sec_edgar |
| stockholders_equity | {"amount": -3799000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2025-12-31 | sec_edgar |
| stockholders_equity | {"amount": 3699000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2025-06-30 | sec_edgar |
| stockholders_equity | {"amount": 3725000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2025-03-31 | sec_edgar |
| stockholders_equity | {"amount": 3298000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2024-12-31 | sec_edgar |
| stockholders_equity | {"amount": 19603000, "concept": "us-gaap:StockholdersEquity", "currency": "USD"} | 2023-12-31 | sec_edgar |
| total_assets | {"amount": 7671000, "concept": "us-gaap:Assets", "currency": "USD"} | 2026-06-30 | sec_edgar |
| total_assets | {"amount": 8161000, "concept": "us-gaap:Assets", "currency": "USD"} | 2026-03-31 | sec_edgar |
| total_assets | {"amount": 7582000, "concept": "us-gaap:Assets", "currency": "USD"} | 2025-12-31 | sec_edgar |
| total_assets | {"amount": 13421000, "concept": "us-gaap:Assets", "currency": "USD"} | 2024-12-31 | sec_edgar |
| total_liabilities | {"amount": 13838000, "concept": "us-gaap:Liabilities", "currency": "USD"} | 2026-06-30 | sec_edgar |
| total_liabilities | {"amount": 13291000, "concept": "us-gaap:Liabilities", "currency": "USD"} | 2026-03-31 | sec_edgar |
| total_liabilities | {"amount": 11381000, "concept": "us-gaap:Liabilities", "currency": "USD"} | 2025-12-31 | sec_edgar |
| total_liabilities | {"amount": 10123000, "concept": "us-gaap:Liabilities", "currency": "USD"} | 2024-12-31 | sec_edgar |
| total_liabilities_and_equity | {"amount": 7671000, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": "US | 2026-06-30 | sec_edgar |
| total_liabilities_and_equity | {"amount": 8161000, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": "US | 2026-03-31 | sec_edgar |
| total_liabilities_and_equity | {"amount": 7582000, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": "US | 2025-12-31 | sec_edgar |
| total_liabilities_and_equity | {"amount": 13421000, "concept": "us-gaap:LiabilitiesAndStockholdersEquity", "currency": "U | 2024-12-31 | sec_edgar |
| website | {"qid": "Q13529450", "url": "http://www.oncolyticsbiotech.com", "via": "wikidata"} | wikidata |
Cite as: FACTANKER, https://factanker.com/entity/c584b34e-93ea-4822-b4f9-418f7edda120